Key facts
- U.S. government representatives are holding secret talks with Berlin on drug prices.
- The Trump administration believes American patients are paying too much.
- The administration wants Europe to contribute to drug costs.
U.S. government representatives are engaged in confidential discussions with Germany concerning drug prices. The Trump administration's stance is that American patients are bearing an excessive cost burden and that European nations should contribute more to these expenses.